Revenue
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | €7.81B | €6.92B | €7.79B | €8.37B | €7.37B | €5.98B |
| Research & development | €54.0M | €53.0M | €89.0M | €87.0M | €80.0M | €77.0M |
| Operating expenses | €472.0M | €445.0M | €576.0M | €603.0M | — | — |
| Operating income | €378.0M | €340.0M | €374.0M | €395.0M | €338.0M | €246.0M |
| Operating margin | 4.84% | 4.92% | 4.80% | 4.72% | 4.58% | 4.11% |
| EBITDA | €620.0M | €472.0M | €507.0M | €556.0M | — | — |
| EBITDA margin | 7.94% | 6.82% | 6.51% | 6.64% | — | — |
| Net income | €358.0M | €283.0M | €223.0M | €248.0M | €164.0M | €80.0M |
| Net profit margin | 4.58% | 4.09% | 2.86% | 2.96% | 2.22% | 1.34% |
| Basic EPSper basic share | €8.08 | €6.39 | €5.08 | €5.64 | €3.76 | €1.80 |
| Diluted EPSper diluted share | €7.84 | €6.20 | €4.92 | €5.47 | €3.66 | €1.76 |